RNN-22662-68261
4 vaccinations
2 coded responses
47 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 275 / NC
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Moderna
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, NauseaAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · HeadacheAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
-
2021-03-10
Survey response — day 14, dose 1MedDRA: Injection site pruritus — Feeling: GoodFree text: Bad itching of the injection site for about 24 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
-
2021-03-24
Dose 2 — Moderna
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-11-15
Dose 3 — Moderna
- 2021-11-15
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-14
- 2021-12-20
- 2021-12-27
- 2022-02-14
- 2022-05-16
-
2022-09-15
Dose 4 — ModernaCo-administered: Flu
- 2022-10-04
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-12-15
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: COVID-19, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Moderna | |
| 2 | 2021-03-24 | Moderna | |
| 3 | 2021-11-15 | Moderna | No |
| 4 | 2022-09-15 | Moderna | Flu |
Free text
Release 5 — day 14, dose 1
Symptoms: Bad itching of the injection site for about 24 hours.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release